Swedish Orphan Biovitrum
309,2
SEK
+1,64 %
SOBI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
4 investorer følger denne virksomhed
+1,64%
-6,13%
-0,13%
+8,72%
+15,81%
+23,38%
+88,75%
+110,82%
+547,97%
www.sobi.com/en/investors
Swedish Orphan Biovitrum, also known as Sobi, is an international pharmaceutical company. The company is focused on the research and development of treatments and belonging services for patients with rare diseases. The products are mainly focused on the treatment of inflammatory and genetic diseases. Sobi also markets specialized wound patches under various brands. The head office is located in Stockholm.
Omsætning
22,12 mia.
EBIT %
18,38 %
P/E
41,39
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
SOBI
Daglig lav / høj pris
302,8 / 310
SEK
Markedsværdi
110,08 mia. SEK
Aktieomsætning
82,69 mio. SEK
Volumen
268 t
Finanskalender
Ekstraordinær generalforsamling
11.12.2024
Årsrapport
05.02.2025
Delårsrapport
29.04.2025
Generalforsamling
08.05.2025
Delårsrapport
15.07.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| Investor | 34,5 % | 34,5 % |
| Morgan Stanley Smith Barney | 9,8 % | 9,8 % |
| Fjärde AP-fonden | 5,8 % | 5,8 % |
| AMF - Försäkring Och Fonder | 4,3 % | 4,3 % |
| State Street Bank and Trust | 4,2 % | 4,2 % |
| JP Morgan Chase Bank NA | 3,2 % | 3,2 % |
| Northern Trust Company, London Branch | 3,1 % | 3,1 % |
| Swedbank Robur fonder | 3,0 % | 3,0 % |
| Handelsbanken Fonder | 2,5 % | 2,5 % |
| BNY Mellon Na (Former Mellon), W9 | 1,5 % | 1,5 % |
ViserAlle indholdstyper
Swedish Orphan Biovitrum AB: David Meek is proposed as new Chair of the Board of Directors of Sobi
Swedish Orphan Biovitrum AB: New data for emapalumab in the treatment of macrophage activation syndrome to be presented at the ACR conference
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools